[1] 高海英,高小冬,黄红丽,等.重组人尿激酶原对ST段抬高型急性心肌梗死患者血浆纤溶因子及血管再通的影响[J].解放军医药杂志,2016,28(8):65-68. [2] Wang JW,Chen YD,Wang CH,et al.Development and validation of clinical risk score predicting the no-reflow phenomenon in patients treated with primary percutaneous coronary intervention for ST-segment elevation myocardial infarction[J].Cardiology,2013,124(3):153. [3] 李智博,王婧,刘斌,等.法舒地尔对急性ST段抬高型心肌梗死患者急诊PCI术中无复流现象及内皮细胞功能的影响[J].中国实验诊断学,2016,20(7):1126-1127. [4] 蒋智慧,张俊峰,龙盼,等.盐酸法舒地尔后适应对大鼠心肌缺血再灌注损伤的保护作用[J].中华老年心脑血管病杂志,2012,14(5):531-534. [5] Ronco C,Mccullough P,Anker SD,et al.Cardiorenal syndromes:report from the consensus conference of the acute dialysis quality initiative[J].Eur Heart J,2010,31(6):703-711. [6] Cruz DN,De Cal M,Garztto F,et al.Plasma neutrophil gelatinase-associated lipocalin is an early biomarker for acute kidney injury in an adult ICU population[J].Intensive Care Med,2010,36(3):444-451. [7] 王治中,梁慧敏.法舒地尔对急性心肌梗死大鼠血流动力学及相关蛋白表达的影响[J].医学临床研究,2011,28(12):2287-2289,2292.
2018, Vol. 35 
